在早期和晚期喘反应后的炎症反应的微RNA剖析
Ruth P Duecker1, Oguzhan Alemdar1,2, Andreas Wimmers1,2
1Department of Pediatrics, Division of Pneumology, Allergology, Infectious Diseases and Gastroenterology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
International journal of molecular sciences
|January 27, 2024
概括
像miR-15a-5p,miR-15b-5p和miR-374a-5p这样的microRNAs (miRNAs) 在经历晚期喘反应的家尘虫过敏喘患者中被下调. 这一发现可能有助于预测过敏原暴露后的晚期喘反应.
科学领域:
- * 免疫学和呼吸系统医学
- * 分子生物学和遗传学
背景情况:
- * 患有室内灰尘虫 (HDM) 过敏的喘患者经常出现早期 (EAR) 和晚期喘反应 (LAR),表明更严重的过敏炎症.
- * 微RNAs (miRNAs) 是喘发病的关键调节者,影响炎症反应.
研究的目的:
- * 为了研究经过支气管过敏原诱导 (BAP) 后患有HDM过敏的轻度喘患者的miRNA概况.
- * 确定与晚期喘反应 (LAR) 发展相关的特定miRNA.
主要方法:
- *17名EAR/无LAR患者和17名EAR加LAR患者在BAP后被分析.
- *下一代测序 (NGS) 用于miRNA分析.
- * 测量了FEV1 (1秒内强迫呼气体积) 和eNO (呼出的氧化).
主要成果:
- * EAR加LAR患者在24小时后表现出更显著的过敏炎症和FEV1的更大下降.
- * NGS-miRNA分析显示,在患有EAR加LAR的患者中,miR-15a-5p,miR-15b-5p和miR-374a-5p的显著下调.
- *这些下调的miRNAs与eNO和最大FEV1降低负相关,并且参与呼吸道重塑的目标基因.
结论:
- * 特定的miRNAs,包括miR-15a-5p,miR-15b-5p和miR-374a-5p,在患有LAR的HDM过敏喘患者中是下调调的.
- *这些miRNA及其向途径与过敏原暴露后的炎症过程有关.
- *已识别的miRNA配置文件可以作为晚期喘反应的预测生物标志物.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298